BLT 0.00% 2.6¢ benitec biopharma limited

10 cents here we come , page-2

  1. 3,083 Posts.
    lightbulb Created with Sketch. 46
    “There has been substantial progress with the IP prosecution and maintenance in the last 12 months. This is an extremely valuable IP portfolio in RNAi and we look forward to additional licensing and collaborations to further develop and commercialise this technology” said Sue MacLeman, CEO, Benitec Ltd.

    onya SUE
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.